The forecast for female breast malignant neoplasms mortality in Japan indicates a gradual increase from 15.72 thousand deaths in 2024 to 16.51 thousand deaths by 2028. Compared to 2023, which recorded a mortality of 15.52 thousand, the Year-on-Year growth rate for 2024 is approximately 1.29%, with subsequent annual increases maintaining a similar trend. The Compound Annual Growth Rate (CAGR) for the period of 2024 to 2028 is estimated to be around 1.22%.
Future trends to watch include advancements in early detection and treatment methods, healthcare policy changes, and public awareness initiatives that could potentially influence these mortality projections favorably. Additionally, demographic shifts such as an aging population could contribute to future trends in mortality rates.
